• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
Header cover image

Global Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Apr 24, 2024

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

151 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NEWBRY

Newbury Pharmaceuticals		kr3.39-3.1%-39.0%kr82.2mkr8.00PS3.6xE112.9%n/a

ZVRA

Zevra Therapeutics		US$4.56-1.7%-12.0%US$191.7mUS$19.00PS6.9xE63.6%n/a

CALTX

Calliditas Therapeutics		kr100.40-0.5%-18.7%kr5.4bkr208.00PS4.5xE48.8%n/a

GTHX

G1 Therapeutics		US$3.99-6.8%62.2%US$218.7mUS$8.50PS2.5xE55.1%n/a

RCEL

AVITA Medical		US$8.57-8.6%-39.2%US$231.7mUS$26.06PS4.4xE62.9%n/a

APLT

Applied Therapeutics		US$4.31-10.8%183.6%US$509.5mUS$11.60PS49.3xE81.9%n/a

OSE

OSE Immunotherapeutics		€5.6415.7%34.3%€121.6m€7.15PS54.6xE92.9%n/a

CLBIO

Corline Biomedical		kr10.40-5.5%-7.6%kr223.5mkr32.00PS6.3xE71.1%n/a

ALDVI

Advicenne		€1.710.7%-58.3%€21.0m€6.90PS6.4xE118.1%n/a

ACR

Acrux		AU$0.061-1.6%8.9%AU$17.7mn/aPS1.6xE115.3%0%

DVYSR

Devyser Diagnostics		kr102.50-2.8%16.7%kr1.7bkr115.39PS9.9xE99.3%n/a

XBRANE

Xbrane Biopharma		kr0.21-39.1%-99.8%kr318.1mn/aPS1.3xE126.0%n/a

SPAGO

Spago Nanomedical		kr0.3413.2%-57.3%kr76.9mn/aPS13xE56.0%n/a

EGTX

Egetis Therapeutics		kr5.93-1.8%-29.7%kr1.7bkr13.13PS30.1xE85.4%n/a

IPH

Innate Pharma		€2.243.5%-16.0%€180.7m€6.27PS2.9xE33.0%n/a

BIOVIC B

Biovica International		kr1.68-29.1%-77.1%kr140.9mkr15.00PS20.2xE83.0%n/a

STX

Shield Therapeutics		UK£0.013-10.5%-82.9%UK£10.4mn/aPS1.7xE89.2%n/a

A206650

EuBiologics		₩13,440.007.1%82.4%₩490.0b₩15,000.00PS7.1xE93.4%n/a

NWRN

Newron Pharmaceuticals		CHF7.00-3.4%62.8%CHF130.4mCHF13.01PS14.7xE53.3%n/a

ALONC

Oncodesign Société Anonyme		€14.420%57.3%€99.4m€18.64PS3xE101.2%n/a

EVOK

Evoke Pharma		US$0.44-19.2%-76.5%US$3.8mUS$7.00PE-0.5xE101.6%n/a

OPTN

OptiNose		US$0.97-5.1%-46.2%US$109.0mUS$3.75PS1.5xE61.6%n/a

INIT

Initiator Pharma		kr9.002.0%60.1%kr476.2mkr24.69PB27.4xE43.4%n/a

URGN

UroGen Pharma		US$14.21-0.2%16.0%US$495.8mUS$38.50PS5.9xE60.5%n/a
Page 1 of 7
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.